Related Experiment Video
Updated: May 4, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
MicroRNA-127-3p Inhibits In Vitro Osteogenesis and Dampens Trauma-Induced Heterotopic Ossification In Vivo
Victor Gustavo Balera Brito1,2, Austin Bell-Hensley3, Hongjun Zheng1
1Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Abstract:
MicroRNAs are small non-coding RNAs that regulate cellular pathways by targeting multiple mRNAs, playing critical roles in skeletal development and homeostasis. Our previous miRNA profiling studies identified higher levels of miR-127-3p in the hypertrophic zone of developing human growth plates while another group found this miRNA to be more highly expressed in murine hindlimb cartilage compared to calvarial bone. Other published work revealed elevated circulating miR-127-3p levels in osteoporotic patients and in long bones of ovariectomized mice. Collectively, these findings suggest a role for miR-127-3p in regulating bone formation. To fill a knowledge gap, we designed a study to determine the function of miR-127-3p in regulating osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells (hBMSCs). While inhibition of miR-127-3p had no effect, mimic overexpression robustly inhibited in vitro osteogenesis. Bulk RNA-sequencing showed a number of cellular pathways affected, including suppression of proliferation-related pathways, which was confirmed by decreased BrdU incorporation. To assess the translational potential of the bone suppressing function of this miRNA, we utilized a pre-clinical mouse model of trauma-induced heterotopic ossification involving Achilles tendon transection. Local delivery of miR-127-3p mimics via peptide-based nanoparticle technology significantly reduced ectopic bone formation at the proximal site of the transected tendon. These studies demonstrate that approaches to overexpress miR-127-3p and induce bone suppressing activity may be of therapeutic value as a means to treat many forms of heterotopic ossification.
Insights
Overexpressing miR-127-3p inhibits bone formation and reduces ectopic bone growth. This microRNA
Area of Science:
- Molecular Biology
- Skeletal Biology
- RNA Biology
Background:
- MicroRNAs regulate cellular pathways and are crucial for skeletal development.
- Elevated miR-127-3p levels are observed in osteoporotic patients and ovariectomized mice.
- Previous studies suggest a role for miR-127-3p in bone formation regulation.
Purpose of the Study:
- To investigate the function of miR-127-3p in osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells (hBMSCs).
- To assess the therapeutic potential of miR-127-3p in treating heterotopic ossification.
Main Methods:
- Overexpression and inhibition of miR-127-3p in hBMSCs.
- Bulk RNA-sequencing to identify affected cellular pathways.
- In vivo studies using a mouse model of heterotopic ossification with local delivery of miR-127-3p mimics via nanoparticle technology.
Main Results:
- miR-127-3p mimic overexpression robustly inhibited in vitro osteogenesis and cell proliferation.
- RNA-sequencing revealed suppression of proliferation-related pathways.
- Local delivery of miR-127-3p mimics significantly reduced ectopic bone formation in a mouse model.
Conclusions:
- miR-127-3p acts as a negative regulator of osteogenic differentiation.
- Overexpression of miR-127-3p suppresses bone formation and may be a therapeutic strategy for heterotopic ossification.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs

